Security key
18914F103
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)
CUSIP: 18914F103
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 127,414,571
- Total 13F value
- $224,456,343
- Share change
- +717,218
- Put/Call ratio
- 58%
- SEC-reported price per share
- $1.76
- Number of holders
- 206
- Value change
- -$795,986
- Number of buys
- 94
- Number of sells
- 79
- Shares outstanding
- 416,598,522
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
206
Top holders
10
CLOV full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
CLOVER HEALTH INVESTMENTS, CORP. /DE SEC filings
CLOVER HEALTH INVESTMENTS, CORP. /DE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 18914F103
Recent filing periods:
Ownership snapshot
Top reported holders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
29 Jan 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.2%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 7.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
7.2%
Peter J. Kuipers
1.4%
Demetrios L. Kouzoukas
0.15%
William G. Robinson Jr.
0.14%
Anna U. Loengard
0.14%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
7.2%
|
$83,180,072
29,813,646 shares
|
$0 | 30 Jun 2025 |
| Peter J. Kuipers |
3/4/5
Chief Financial Officer
|
1.4%
|
$13,301,795
5,758,353 shares
|
— | 29 Jan 2026 |
| Demetrios L. Kouzoukas |
3/4/5
Director
|
0.15%
|
$1,424,174
605,980 shares
|
— | 06 Jan 2026 |
| William G. Robinson Jr. |
3/4/5
Director
|
0.14%
|
$1,405,389
597,987 shares
|
— | 06 Jan 2026 |
| Anna U. Loengard |
3/4/5
Director
|
0.14%
|
$1,374,081
584,666 shares
|
+$68,755 | 06 Jan 2026 |
| Thomas L. Tran |
3/4/5
Director
|
0.04%
|
$423,104
180,029 shares
|
— | 06 Jan 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
206
Shares
127,414,571
Rows available
206
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
192
Q1 2026 holders
206
Holder diff
14
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend